The Most Important Facts About Freeport-McMoRan

By Susan Ramirez • Wednesday, December 20 16:14 • Permanent Link

Freeport-McMoRan logged a -2.0% change during today's evening session, and is now trading at a price of $41.34 per share. The S&P 500 index moved -1.0%. FCX's trading volume is 9,071,925 compared to the stock's average volume of 11,613,538.

Freeport-McMoRan trades -8.34% away from its average analyst target price of $45.1 per share. The 18 analysts following the stock have set target prices ranging from $37.0 to $57.0, and on average have given Freeport-McMoRan a rating of buy.

Anyone interested in buying FCX should be aware of the facts below:

Freeport-McMoRan has moved 9.7% over the last year, and the S&P 500 logged a change of 22.9%
Based on its trailing earnings per share of 1.5, Freeport-McMoRan has a trailing 12 month Price to Earnings (P/E) ratio of 27.6 while the S&P 500 average is 15.97
FCX has a forward P/E ratio of 23.0 based on its forward 12 month price to earnings (EPS) of $1.8 per share
The company has a price to earnings growth (PEG) ratio of -1.73 — a number near or below 1 signifying that Freeport-McMoRan is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 3.6 compared to its sector average of 2.07
Freeport-McMoRan Inc. engages in the mining of mineral properties in North America, South America, and Indonesia.
Based in Phoenix, the company has 25,600 full time employees and a market cap of $59.28 Billion. Freeport-McMoRan currently returns an annual dividend yield of 1.4%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.